March 5, 2020 / 12:48 PM / in a month

BRIEF-Arbutus Biopharma Reports Q4 Loss Per Share Of $2.89

March 5 (Reuters) - Arbutus Biopharma Corp:

* ARBUTUS REPORTS FOURTH QUARTER AND YEAR END 2019 FINANCIAL RESULTS, CONFIRMS 2020 CORPORATE OBJECTIVES AND PROVIDES PIPELINE UPDATE

* Q4 LOSS PER SHARE $2.89

* Q4 EARNINGS PER SHARE ESTIMATE $-0.36 — REFINITIV IBES DATA

* ARBUTUS BIOPHARMA - ENDED YEAR WITH $90.8 MILLION IN CASH, CASH EQUIVALENTS & SHORT-TERM INVESTMENTS, IS SUFFICIENT TO FUND OPERATIONS INTO MID-2021

* ARBUTUS BIOPHARMA - EXPECTS TO UTILIZE BETWEEN $54 TO $58 MILLION OF CASH & INVESTMENTS TO FUND OPERATIONS IN 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below